Rasagiline
NDC 47781-690, Rasagiline, tablet, from Alvogen, Inc..
- Product NDC
- 47781-690
- Status
- Listed
- Labeler
- Alvogen, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201970
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/47781-690 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RASAGILINE MESYLATE1 mg/1
Pharmacologic classes
Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 47781-690-30 | 47781069030 | 30 TABLET in 1 BOTTLE, PLASTIC (47781-690-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a62a9946-755f-47d0-afe6-edc8f7d641feNADAC price for package 47781069030
GET /v1/drugs/nadac/47781069030
Use it
Look up 47781-690 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/47781-690 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 47781-690. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.